Cargando…

Co-Encapsulated Synbiotics and Immobilized Probiotics in Human Health and Gut Microbiota Modulation

Growing interest in the development of innovative functional products as ideal carriers for synbiotics, e.g., nutrient bars, yogurt, chocolate, juice, ice cream, and cheese, to ensure the daily intake of probiotics and prebiotics, which are needed to maintain a healthy gut microbiota and overall wel...

Descripción completa

Detalles Bibliográficos
Autores principales: Kvakova, Monika, Bertkova, Izabela, Stofilova, Jana, Savidge, Tor C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230215/
https://www.ncbi.nlm.nih.gov/pubmed/34200108
http://dx.doi.org/10.3390/foods10061297
_version_ 1783713155804823552
author Kvakova, Monika
Bertkova, Izabela
Stofilova, Jana
Savidge, Tor C.
author_facet Kvakova, Monika
Bertkova, Izabela
Stofilova, Jana
Savidge, Tor C.
author_sort Kvakova, Monika
collection PubMed
description Growing interest in the development of innovative functional products as ideal carriers for synbiotics, e.g., nutrient bars, yogurt, chocolate, juice, ice cream, and cheese, to ensure the daily intake of probiotics and prebiotics, which are needed to maintain a healthy gut microbiota and overall well-being, is undeniable and inevitable. This review focuses on the modern approaches that are currently being developed to modulate the gut microbiota, with an emphasis on the health benefits mediated by co-encapsulated synbiotics and immobilized probiotics. The impact of processing, storage, and simulated gastrointestinal conditions on the viability and bioactivity of probiotics together with prebiotics such as omega-3 polyunsaturated fatty acids, phytochemicals, and dietary fibers using various delivery systems are considered. Despite the proven biological properties of synbiotics, research in this area needs to be focused on the proper selection of probiotic strains, their prebiotic counterparts, and delivery systems to avoid suppression of their synergistic or complementary effect on human health. Future directions should lead to the development of functional food products containing stable synbiotics tailored for different age groups or specifically designed to fulfill the needs of adjuvant therapy.
format Online
Article
Text
id pubmed-8230215
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82302152021-06-26 Co-Encapsulated Synbiotics and Immobilized Probiotics in Human Health and Gut Microbiota Modulation Kvakova, Monika Bertkova, Izabela Stofilova, Jana Savidge, Tor C. Foods Review Growing interest in the development of innovative functional products as ideal carriers for synbiotics, e.g., nutrient bars, yogurt, chocolate, juice, ice cream, and cheese, to ensure the daily intake of probiotics and prebiotics, which are needed to maintain a healthy gut microbiota and overall well-being, is undeniable and inevitable. This review focuses on the modern approaches that are currently being developed to modulate the gut microbiota, with an emphasis on the health benefits mediated by co-encapsulated synbiotics and immobilized probiotics. The impact of processing, storage, and simulated gastrointestinal conditions on the viability and bioactivity of probiotics together with prebiotics such as omega-3 polyunsaturated fatty acids, phytochemicals, and dietary fibers using various delivery systems are considered. Despite the proven biological properties of synbiotics, research in this area needs to be focused on the proper selection of probiotic strains, their prebiotic counterparts, and delivery systems to avoid suppression of their synergistic or complementary effect on human health. Future directions should lead to the development of functional food products containing stable synbiotics tailored for different age groups or specifically designed to fulfill the needs of adjuvant therapy. MDPI 2021-06-04 /pmc/articles/PMC8230215/ /pubmed/34200108 http://dx.doi.org/10.3390/foods10061297 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Kvakova, Monika
Bertkova, Izabela
Stofilova, Jana
Savidge, Tor C.
Co-Encapsulated Synbiotics and Immobilized Probiotics in Human Health and Gut Microbiota Modulation
title Co-Encapsulated Synbiotics and Immobilized Probiotics in Human Health and Gut Microbiota Modulation
title_full Co-Encapsulated Synbiotics and Immobilized Probiotics in Human Health and Gut Microbiota Modulation
title_fullStr Co-Encapsulated Synbiotics and Immobilized Probiotics in Human Health and Gut Microbiota Modulation
title_full_unstemmed Co-Encapsulated Synbiotics and Immobilized Probiotics in Human Health and Gut Microbiota Modulation
title_short Co-Encapsulated Synbiotics and Immobilized Probiotics in Human Health and Gut Microbiota Modulation
title_sort co-encapsulated synbiotics and immobilized probiotics in human health and gut microbiota modulation
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230215/
https://www.ncbi.nlm.nih.gov/pubmed/34200108
http://dx.doi.org/10.3390/foods10061297
work_keys_str_mv AT kvakovamonika coencapsulatedsynbioticsandimmobilizedprobioticsinhumanhealthandgutmicrobiotamodulation
AT bertkovaizabela coencapsulatedsynbioticsandimmobilizedprobioticsinhumanhealthandgutmicrobiotamodulation
AT stofilovajana coencapsulatedsynbioticsandimmobilizedprobioticsinhumanhealthandgutmicrobiotamodulation
AT savidgetorc coencapsulatedsynbioticsandimmobilizedprobioticsinhumanhealthandgutmicrobiotamodulation